Skin cells turned cancer-killing stem cells hunt down and destroy the deadly remnants inevitably left behind when a brain tumor is surgically removed
In a first for medical science, University of North Carolina at Chapel Hill pharmacy researchers turn skin cells into cancer-hunting stem cells that destroy brain tumors known as glioblastoma – a discovery that can offer, for the first time in more than 30 years, a new and more effective treatment for the disease.
The technique, reported in Nature Communications, builds upon the newest version of the Nobel Prize-winning technology from 2007, which allowed researchers to turn skin cells into embryonic-like stem cells. Researchers hailed the possibilities for use in regenerative medicine and drug screening. Now, researchers have found a new use: killing brain cancer.
“Patients desperately need a better standard of care,” said Shawn Hingtgen, Ph.D., an assistant professor in the UNC Eshelman School of Pharmacy and member of the Lineberger Comprehensive Care Center, who led the study.
The survival rate beyond two years for a patient with a glioblastoma is 30 percent because it is so difficult to treat. Even if a surgeon removes most of the tumor, it’s nearly impossible to get the invasive, cancerous tendrils that spread deeper into the brain and inevitably the remnants grow back. Most patients die within a year and a half of their diagnosis.
Hingtgen and his team want to improve those statistics by developing a new personalized treatment for glioblastoma that starts with a patient’s own skin cells, with the goal of getting rid of the cancerous tendrils, effectively killing the glioblastoma.
In their work, Hingtgen and his team reprogram skin cells known as fibroblasts – which produce collagen and connective tissue — to become induced neural stem cells. Working with mice, Hingtgen’s team showed that these neural stem cells have an innate ability to move throughout the brain and home in on and kill any remaining cancer cells. The team also showed that these stem cells could be engineered to produce a tumor-killing protein, adding another blow to the cancer.
Depending on the type of tumor, the Hingtgen’s team increased survival time of the mice 160 to 220 percent. Next steps will focus on human stem cells and testing more effective anti-cancer drugs that can be loaded into the tumor-seeking neural stem cells.
“Our work represents the newest evolution of the stem-cell technology that won the Nobel Prize in 2012,” Hingtgen said. “We wanted to find out if these induced neural stem cells would home in on cancer cells and whether they could be used to deliver a therapeutic agent. This is the first time this direct reprogramming technology has been used to treat cancer.”
The Latest on: Induced neural stem cells
via Google News
The Latest on: Induced neural stem cells
- NBRC scientists pave the way for a better understanding of Autismon February 3, 2020 at 5:23 am
in determining the fate of human-induced pluripotent stem cells (iPSCs)-derived neural stem cells (hiNSCs). The iPSC derived NSCs are considered as ideal models to study neurodevelopmental disorders ...
- Stem Cells, But Which Flavour?on February 1, 2020 at 1:10 pm
Neural stem cells can be found in adults, but also the fetal brain ... from which any number of other derivatives can be created. The second type are called induced pluripotent stem cells (iPS cells).
- Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interactionon January 28, 2020 at 11:34 am
Upon induced neural differentiation, some red fluorescent cells showed morphology of fully differentiated neural cells, indicating fusion between the cancer and neural stem cells. These fusion hybrids ...
- StemoniX's microBrain® to be Featured in Podium Presentation at SLAS 2020 International Conference & Exhibitionon January 27, 2020 at 8:01 am
/PRNewswire/ -- StemoniX, a biotech company revolutionizing how new medicines are discovered, announced today that its Director of Applications, ...
- p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoidson January 23, 2020 at 2:54 am
In this study, we take advantage of human induced pluripotent stem (iPS) cell-derived neural stem cells and brain organoids to study the role of p53 during human brain development. We knocked down (KD ...
- Cerebral organoid model provides clues about how to prevent virus-induced brain cell deathon November 25, 2019 at 4:00 pm
Neurons -- the primary brain cells of the central nervous system -- evolve from neural stem cells and during development ... protected neurons from virus-induced death. The scientists plan ...
- Pharmacology Safety Studies Using Neural Stem Cellson October 15, 2019 at 1:25 am
Induced pluripotent stem cells (iPSCs ... Therefore, generating a cortical co-culture from neural stem cells that contains both neurons and astrocytes is a much more representative model of ...
- Induced-Pluripotent Stem Cell approaches to model diseaseon September 20, 2019 at 1:33 pm
To elucidate the anatomical and physiological deficits found in the patients with schizophrenia, this project uses induced- Pluripotent Stem Cells (iPSCs) into an animal system and imaging the ...
- Tumor-homing cytotoxic human induced neural stem cells for cancer therapyon March 3, 2019 at 4:00 pm
2 UNC Human Pluripotent Stem Cell Core Facility, Department of Genetics, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. 3 Department of Neurosurgery, ...
- Human blood cells can be directly reprogrammed into neural stem cellson December 28, 2018 at 4:11 am
For the first time, Trumpp's team has succeeded in reprogramming mature human cells in such a way that a defined type of induced neural stem cell is produced that can multiply almost indefinitely.
via Bing News